All News

ADA's theme for American Diabetes Month encourages healthier eating to promote better disease management and prevention.

Nearly 15% of federal marketplace insurance plans completely lack in-network physicians for at least one specialty.

A blood test that can detect mutations in the androgen receptor can predict response to abiraterone in prostate cancer.

A list that seeks both the causes and effects of obesity.

Independent community pharmacists can network across diverse practice settings to improve patients' adherence to health-promoting prescription drug regimens.

New research, published in JAMA Oncology, presents evidence of how the use of disease-specific hashtags on Twitter can help those with common interests collectively share information.

What we're reading, November 5, 2015: defensive medicine actually does reduce malpractice risk; patients would like more options for using digital technology with their healthcare; and Americans are eating healthier.

The deal is part of Sanofi's effort to recover ground in the diabetes market.

Physicians broadly mistrust healthcare insurers and believe they interfere with their ability to provide high-quality patient care

Published in the journal Cancer, the study evaluated the short-term and long-term costs of treating patients with low-risk prostate cancer across the entire care spectrum.

The bipartisan panel has asked 4 drug makers, including Turing Pharmaceuticals, to submit documents to the US Senate's Special Committee on Aging.

According to a study published in The International Journal of Cancer, tubal ligation can reduce the risk of serous, endometrioid, and clear cell ovarian carcinoma.

Departing Governor Steve Beshear's full embrace of the Affordable Care Act brought health coverage to 500,000 people in Kentucky, including many who had never had insurance. Preventive services increased by more than 100%.

What we're reading, November 4, 2015: drug deaths become the next big 2016 presidential campaign issue; and Blue Shield of California and Anthem Blue Cross receive large fines for misleading information about Affordable Care Act Plans.

Approximately half of patients prescribed statins for lowering cholesterol discontinue use within the first year and the adherence rate only goes down from there.

A new research study published in the Journal of Dermatology has found that propranolol, a commonly used antihypertensive agent, could substantially reduce proliferation of angiosarcoma.

Fifty organizations, including the American Society of Clinical Oncology, have expressed their confidence in Robert Califf, MD, to lead the FDA.

The study found that drugs to treat high cholesterol and diabetes were among those experiencing increased use between 1999-2000 and 2011-2012.

There is not a lot of information about primary medication nonadherence, but it could have a huge impact on patients, as discussed by a speaker at the Academy of Managed Care Pharmacy Nexus 2015 meeting.

This year's Nobel Prize winner in economics and his wife uncover sad statistics on how substance abuse and suicide are taking their toll on white Americans at midlife. Princeton's Angus Deaton speculates that the trends reflect the broader picture of inequality.

The finding that chronic statin therapy lowers vaccine effectiveness in elderly individuals may have implications for future vaccine recommendations.

After melanoma and non-small cell lung cancer, the FDA has granted Breakthrough Therapy status to pembrolizumab in advanced colorectal cancer patients with mismatched repair deficiency.

What we're reading, November 3, 2015: off-label drug use is associated with a higher risk of adverse drug events; CMS finalizes its rule for advanced care planning for end-of-life care; and Californians send measure to cut drug prices to the vote.

Perioperative medication errors and adverse drug events occur in every second operation and in 5% of observed drug administrations, according to a study from Massachusetts General Hospital.

As has been the case in other states, Virginia seeks a solution to rising costs for medically fragile patients. Lawmakers have been unwilling to expand Medicaid and likely will not until a cost-containment plan is found.

The new meta-analysis was sponsored by the American Diabetes Association and the National Institutes of Health.

Some progress and a lot of room for improvement in the latest Hospital Safety Score report.

What we're reading, November 2, 2015: third open enrollment under the Affordable Care Act kicks off; common medical tests are being done inaccurately; and hospitals and the government settle over cardiac device implants.

During the last 5 years of life, the cost of dementia eclipses that of other diseases, like cancer and heart disease, according to a study from the National Institutes of Health.

Healthcare spending for the privately insured increased 3.4% in 2014 despite a decline in the use of healthcare services.